{"transactions":[{"id":2894956,"issuer":{"id":136038,"kind":"organization","name":"Population Health Investment Co., Inc.","symbol":"PHIC"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2021-01-26T20:55:17.000Z","date":"2021-01-26","kind":"other","acquired":true,"shares":43125,"price":250,"value":10781250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-249756) under the heading \"Description of Securities--Founder Shares\", the Class B ordinary shares, par value $0.0001 per share, will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with Ms. Champsi's election as an independent director of the issuer, 43,125 Class B ordinary shares of the issuer were transferred by Population Health Investment Holding, Inc. to Ms. Champsi for $250.00, or approximately $0.0058 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with Ms. Champsi's election as an independent director of the issuer, 43,125 Class B ordinary shares of the issuer were transferred by Population Health Investment Holding, Inc. to Ms. Champsi for $250.00, or approximately $0.0058 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-249756) under the heading \"Description of Securities--Founder Shares\", the Class B ordinary shares, par value $0.0001 per share, will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-249756) under the heading \"Description of Securities--Founder Shares\", the Class B ordinary shares, par value $0.0001 per share, will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In connection with Ms. Champsi's election as an independent director of the issuer, 43,125 Class B ordinary shares of the issuer were transferred by Population Health Investment Holding, Inc. to Ms. Champsi for $250.00, or approximately $0.0058 per share."}],"balance_after":43125,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":43125},"source":{"system":"sec-edgar","filing":"0000899243-21-003406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000089924321003406/doc4.xml","form_type":"4"}},{"id":3303106,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":1,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":3,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":4,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":5,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":6,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":7,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":8,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":9,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T18:24:58.000Z","date":"2020-01-22","kind":"other","acquired":true,"shares":6837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Guy P. Nohra in connection with the pro-rata distribution described in footnote (1) herein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Guy P. Nohra in connection with the pro-rata distribution described in footnote (1) herein."}],"balance_after":6837,"source":{"system":"sec-edgar","filing":"0001209191-20-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919120004922/doc4.xml","form_type":"4"}},{"id":3303105,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":1,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":3,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":4,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":5,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":6,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":7,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":8,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":9,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T18:24:58.000Z","date":"2020-01-22","kind":"other","acquired":true,"shares":11539,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Alta Bioequities, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Alta Bioequities, L.P. in connection with the pro-rata distribution described in footnote (5) herein.  Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Alta Bioequities, L.P. in connection with the pro-rata distribution described in footnote (5) herein.  Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":11539,"source":{"system":"sec-edgar","filing":"0001209191-20-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919120004922/doc4.xml","form_type":"4"}},{"id":3303104,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":1,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":3,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":4,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":5,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":6,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":7,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":8,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":9,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T18:24:58.000Z","date":"2020-01-22","kind":"other","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hudson Capital LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Hudson Capital, LLC, a limited liability company of which Peter A. Hudson is the managing member, in connection with the pro-rata distribution described in footnote (5) herein. Mr. Hudson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Hudson Capital, LLC, a limited liability company of which Peter A. Hudson is the managing member, in connection with the pro-rata distribution described in footnote (5) herein. Mr. Hudson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":11538,"source":{"system":"sec-edgar","filing":"0001209191-20-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919120004922/doc4.xml","form_type":"4"}},{"id":3303103,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":1,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":3,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":4,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":5,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":6,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":7,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":8,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":9,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T18:24:58.000Z","date":"2020-01-22","kind":"other","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Robert J. More in connection with the pro-rata distribution described in footnote (5) herein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Represents the acquisition of the shares of Common Stock of the Issuer by Robert J. More in connection with the pro-rata distribution described in footnote (5) herein."}],"balance_after":11538,"source":{"system":"sec-edgar","filing":"0001209191-20-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919120004922/doc4.xml","form_type":"4"}},{"id":3303102,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":1,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":3,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":4,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":5,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":6,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":7,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":8,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":9,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T18:24:58.000Z","date":"2020-01-22","kind":"other","acquired":false,"shares":34615,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By APNG I Management"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by APNG I Management, without consideration, to its members."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919120004922/doc4.xml","form_type":"4"}},{"id":3303101,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":1,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":3,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":4,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":5,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":6,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":7,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":8,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":9,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T18:24:58.000Z","date":"2020-01-22","kind":"other","acquired":true,"shares":34615,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By APNG I Management"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. (\"APNG I\"), without consideration, to its general partner and limited partners."}],"balance_after":34615,"source":{"system":"sec-edgar","filing":"0001209191-20-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919120004922/doc4.xml","form_type":"4"}},{"id":3303100,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":1,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":3,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":4,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":5,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":6,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":7,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":8,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":9,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T18:24:58.000Z","date":"2020-01-22","kind":"other","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. (\"APNG I\"), without consideration, to its general partner and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 2,557,377 shares held of record by APNG I and 7,961,823 shares held of record by Alta Partners VIII, L.P. (\"Alta VIII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their respective pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC (\"APNG I Management\"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their respective pecuniary interests therein."}],"balance_after":10519200,"source":{"system":"sec-edgar","filing":"0001209191-20-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919120004922/doc4.xml","form_type":"4"}},{"id":3804124,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":18698578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":514211},"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3804123,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":9449318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":382698},"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3804122,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":12387324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":458331},"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3804121,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":10201769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":589661},"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3804120,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":514211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":1944901,"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3804119,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":382698,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":1430690,"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3804118,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":458331,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":1047992,"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3804117,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":3,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":63327,"kind":"person","name":"JANNEY DANIEL","position":4,"cik":"0001198325","reported_name":"JANNEY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":5,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T17:12:29.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":589661,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares directly held by Alta Partners VIII, L.P. (\"Alta VIII\") are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."}],"balance_after":589661,"source":{"system":"sec-edgar","filing":"0001209191-18-052831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919118052831/doc4.xml","form_type":"4"}},{"id":3862976,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":3,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":4,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":5,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":6,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":7,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":8,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-07-23T17:01:38.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":1239007,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC (\"APNG I Management\"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"APNG I owns 504,547 shares of Series B Preferred Stock. Alta VIII owns 734,460 shares of Series B Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1239007},"source":{"system":"sec-edgar","filing":"0001209191-18-043627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919118043627/doc4.xml","form_type":"4"}},{"id":3862975,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":3,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":4,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":5,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":6,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":7,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":8,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-07-23T17:01:38.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":10030193,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC (\"APNG I Management\"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"APNG I owns 2,941,718 shares of Series A Preferred Stock. Alta VIII owns 7,088,475 shares of Series A Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10030193},"source":{"system":"sec-edgar","filing":"0001209191-18-043627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919118043627/doc4.xml","form_type":"4"}},{"id":3862974,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":3,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":4,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":5,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":6,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":7,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":8,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-23T17:01:38.000Z","date":"2018-07-23","kind":"purchase","acquired":true,"shares":250000,"price":18,"value":4500000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC (\"APNG I Management\"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Consists of 3,557,377 shares held of record by APNG I and 7,961,823 shares held of record by Alta VIII."}],"balance_after":11519200,"source":{"system":"sec-edgar","filing":"0001209191-18-043627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919118043627/doc4.xml","form_type":"4"}},{"id":3862973,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":110408,"kind":"organization","name":"Alta Partners VIII, L.P.","position":1,"cik":"0001399763","reported_name":"Alta Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110407,"kind":"organization","name":"Alta Partners Management VIII, LLC","position":2,"cik":"0001399894","reported_name":"Alta Partners Management VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144083,"kind":"organization","name":"Alta Partners NextGen Fund I Management, LLC","position":3,"cik":"0001736001","reported_name":"Alta Partners NextGen Fund I Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144084,"kind":"organization","name":"Alta Partners NextGen Fund I, L.P.","position":4,"cik":"0001698110","reported_name":"Alta Partners NextGen Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":5,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135397,"kind":"person","name":"Hudson Peter A","position":6,"cik":"0001674884","reported_name":"Hudson Peter A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24127,"kind":"person","name":"MORE ROBERT J","position":7,"cik":"0001207792","reported_name":"MORE ROBERT J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39204,"kind":"person","name":"NOHRA GUY P","position":8,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-23T17:01:38.000Z","date":"2018-07-23","kind":"exercise","acquired":true,"shares":11269200,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of 3,446,265 shares held of record by Alta Partners NextGen Fund I, L.P. (\"APNG I\") and 7,822,935 shares held of record by Alta Partners VIII, L.P. (\"Alta VIII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC (\"Alta Management VIII\"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC (\"APNG I Management\"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein."}],"balance_after":11269200,"source":{"system":"sec-edgar","filing":"0001209191-18-043627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1736001/000120919118043627/doc4.xml","form_type":"4"}},{"id":4190864,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-10-05T20:20:18.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":8810,"price":88.79,"value":782239.9,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of Company common stock held by the Reporting Person, other than the shares described in Note 3 below, was validly tendered for $180.00 per share in cash, without interest and subject to any required withholding of taxes."},{"field":"date","element":"transactionDate","label":"F2","text":"On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Parent (the \"Merger\"), and, pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $180.00 (the \"per-share merger consideration\"), without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration less the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option provided for vesting in 12 equal monthly installments following June 20, 2017."}],"balance_after":0,"derivative":{"exercise_price":91.21,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":8810},"source":{"system":"sec-edgar","filing":"0001209191-17-056230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117056230/doc4.xml","form_type":"4"}},{"id":4190863,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-10-05T20:20:18.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":7000,"price":129.13,"value":903910.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of Company common stock held by the Reporting Person, other than the shares described in Note 3 below, was validly tendered for $180.00 per share in cash, without interest and subject to any required withholding of taxes."},{"field":"date","element":"transactionDate","label":"F2","text":"On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Parent (the \"Merger\"), and, pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $180.00 (the \"per-share merger consideration\"), without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration less the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option provided for vesting in 12 equal monthly installments following June 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":50.87,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-17-056230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117056230/doc4.xml","form_type":"4"}},{"id":4190862,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-10-05T20:20:18.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":120.77,"value":1207700.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of Company common stock held by the Reporting Person, other than the shares described in Note 3 below, was validly tendered for $180.00 per share in cash, without interest and subject to any required withholding of taxes."},{"field":"date","element":"transactionDate","label":"F2","text":"On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Parent (the \"Merger\"), and, pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $180.00 (the \"per-share merger consideration\"), without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration less the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option provided for vesting in 12 equal monthly installments following June 9, 2015."}],"balance_after":0,"derivative":{"exercise_price":59.23,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-056230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117056230/doc4.xml","form_type":"4"}},{"id":4190861,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-10-05T20:20:18.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":178.65,"value":8932500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of Company common stock held by the Reporting Person, other than the shares described in Note 3 below, was validly tendered for $180.00 per share in cash, without interest and subject to any required withholding of taxes."},{"field":"date","element":"transactionDate","label":"F2","text":"On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Parent (the \"Merger\"), and, pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $180.00 (the \"per-share merger consideration\"), without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration less the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option provided for vesting of 1/36th of the shares subject thereto on February 28, 2014, and for vesting of the remaining shares subject thereto in 35 equal monthly installments commencing March 30, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2024-03-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-056230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117056230/doc4.xml","form_type":"4"}},{"id":4190860,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T20:20:18.000Z","date":"2017-10-03","kind":"disposition_to_issuer","acquired":false,"shares":1807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of Company common stock held by the Reporting Person, other than the shares described in Note 3 below, was validly tendered for $180.00 per share in cash, without interest and subject to any required withholding of taxes."},{"field":"date","element":"transactionDate","label":"F2","text":"On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Parent (the \"Merger\"), and, pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $180.00 (the \"per-share merger consideration\"), without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Company common stock underlying restricted stock units with respect to Company common stock, including all time-vesting and all performance-vesting restricted stock units, held by a non-employee director of the Company (each a \"Director Restricted Stock Unit\").  Pursuant to the terms of the Merger Agreement, each Director Restricted Stock Unit held by the Reporting Person fully vested and was cancelled and converted into the right to receive a cash payment equal to the product of (A) $180.00, multiplied by (B) the total number of shares of Company common stock subject to such Director Restricted Stock Unit."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-056230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117056230/doc4.xml","form_type":"4"}},{"id":4190859,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T20:20:18.000Z","date":"2017-10-03","kind":"other","acquired":false,"shares":61467,"price":180,"value":11064060.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 27, 2017, Kite Pharma, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Gilead Sciences, Inc., a Delaware corporation (\"Parent\"), and Dodgers Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of Company common stock held by the Reporting Person, other than the shares described in Note 3 below, was validly tendered for $180.00 per share in cash, without interest and subject to any required withholding of taxes."},{"field":"date","element":"transactionDate","label":"F2","text":"On October 3, 2017, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Parent (the \"Merger\"), and, pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $180.00 (the \"per-share merger consideration\"), without interest and subject to any required withholding of taxes."}],"balance_after":1807,"source":{"system":"sec-edgar","filing":"0001209191-17-056230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117056230/doc4.xml","form_type":"4"}},{"id":4190858,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T20:20:18.000Z","date":"2017-09-29","kind":"gift","acquired":false,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63274,"source":{"system":"sec-edgar","filing":"0001209191-17-056230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117056230/doc4.xml","form_type":"4"}},{"id":4274360,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-06-22T14:49:28.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":8810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in 12 successive equal monthly installments following the date of grant."}],"balance_after":8810,"derivative":{"exercise_price":91.21,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":8810},"source":{"system":"sec-edgar","filing":"0001209191-17-041312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117041312/doc4.xml","form_type":"4"}},{"id":4274359,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-22T14:49:28.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":2410,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66074,"source":{"system":"sec-edgar","filing":"0001209191-17-041312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117041312/doc4.xml","form_type":"4"}},{"id":4278765,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-16T17:41:53.000Z","date":"2017-06-16","kind":"sale","acquired":false,"shares":5450,"price":88.11,"value":480199.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the transfer from the reporting person to APVIII of 488 shares of the Issuer's common stock on June 1, 2017.  The reporting person has been awarded certain restricted stock units in her capacity as a director of the Company (the \"RSUs\"), and she is contractually obligated, as a managing director of APVIII, to transfer to APVIII, for no consideration, all shares of common stock that she receives upon the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.96 to $88.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-040610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117040610/doc4.xml","form_type":"4"}},{"id":4278764,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-16T17:41:53.000Z","date":"2017-06-14","kind":"sale","acquired":false,"shares":15000,"price":90.4,"value":1356000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer from the reporting person to APVIII of 488 shares of the Issuer's common stock on June 1, 2017.  The reporting person has been awarded certain restricted stock units in her capacity as a director of the Company (the \"RSUs\"), and she is contractually obligated, as a managing director of APVIII, to transfer to APVIII, for no consideration, all shares of common stock that she receives upon the vesting of the RSUs."}],"balance_after":63664,"source":{"system":"sec-edgar","filing":"0001209191-17-040610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117040610/doc4.xml","form_type":"4"}},{"id":4340299,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-01T18:52:23.000Z","date":"2017-04-28","kind":"sale","acquired":false,"shares":2617,"price":82.59,"value":216138.03,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.50 to $82.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":4962,"source":{"system":"sec-edgar","filing":"0001209191-17-029021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117029021/doc4.xml","form_type":"4"}},{"id":4340298,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-01T18:52:23.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":16551,"price":82.77,"value":1369926.27,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.50 to $83.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":7579,"source":{"system":"sec-edgar","filing":"0001209191-17-029021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117029021/doc4.xml","form_type":"4"}},{"id":4344470,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T17:38:25.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":200,"price":83.06,"value":16612.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":24130,"source":{"system":"sec-edgar","filing":"0001209191-17-028231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117028231/doc4.xml","form_type":"4"}},{"id":4344469,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T17:38:25.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":51112,"price":82.72,"value":4227984.64,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.05 to $83.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":24330,"source":{"system":"sec-edgar","filing":"0001209191-17-028231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117028231/doc4.xml","form_type":"4"}},{"id":4344468,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T17:38:25.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":15316,"price":83.29,"value":1275669.64,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.05 to $83.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":75442,"source":{"system":"sec-edgar","filing":"0001209191-17-028231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117028231/doc4.xml","form_type":"4"}},{"id":4344467,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T17:38:25.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":31467,"price":82.56,"value":2597915.52,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.05 to $83.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":90758,"source":{"system":"sec-edgar","filing":"0001209191-17-028231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117028231/doc4.xml","form_type":"4"}},{"id":4344466,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T17:38:25.000Z","date":"2017-04-24","kind":"sale","acquired":false,"shares":25818,"price":82.34,"value":2125854.12,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.07 to $82.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":122225,"source":{"system":"sec-edgar","filing":"0001209191-17-028231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117028231/doc4.xml","form_type":"4"}},{"id":4351394,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T21:24:05.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":100,"price":83.06,"value":8306.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":148043,"source":{"system":"sec-edgar","filing":"0001209191-17-027183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117027183/doc4.xml","form_type":"4"}},{"id":4351393,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T21:24:05.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":43001,"price":82.48,"value":3546722.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.05 to $83.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":148143,"source":{"system":"sec-edgar","filing":"0001209191-17-027183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117027183/doc4.xml","form_type":"4"}},{"id":4351392,"issuer":{"id":172664,"kind":"organization","name":"Kite Pharma, Inc.","symbol":"KITE"},"owners":[{"id":143450,"kind":"person","name":"CHAMPSI FARAH","position":1,"cik":"0001198321","reported_name":"CHAMPSI FARAH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T21:24:05.000Z","date":"2017-04-13","kind":"sale","acquired":false,"shares":72275,"price":82.39,"value":5954737.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.05 to $82.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the disposition by Alta Partners VIII, L.P. (\"APVIII\") of 1,500,000 shares of the Issuer's common stock in a pro-rata distribution to its limited partners on October 19, 2016.  Also reflects the transfer from the reporting person to APVIII of 487 shares of the Issuer's common stock on January 26, 2017 and 975 shares of the Issuer's common stock on March 23, 2017.  The reporting person has been awarded certain restricted stock units in her capacity as a director of the Company (the \"RSUs\"), and she is contractually obligated, as a managing director of APVIII, to transfer to APVIII, for no consideration, all shares of common stock that she receives upon the vesting of the RSUs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by APVIII. Alta Partners Management VIII, LLC (\"APMVIII\") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein."}],"balance_after":191144,"source":{"system":"sec-edgar","filing":"0001209191-17-027183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1198321/000120919117027183/doc4.xml","form_type":"4"}}]}